Mark R. Gilbert, M.D.
|Neuro-Oncology||University of Texas, MD Anderson Cancer Center|
Mean distance: 106866
ParentsSign in to add mentor
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Soffietti R, Bettegowda C, Mellinghoff IK, et al. (2022) Liquid biopsy in gliomas: a RANO review and proposals for clinical applications. Neuro-Oncology|
|Doucet-O'Hare TT, Rosenblum JS, Shah AH, et al. (2021) Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors. Journal of Personalized Medicine. 11|
|Yu G, Pang Y, Merchant M, et al. (2021) Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas. Cancers. 13|
|Ruiz-Rodado V, Dowdy T, Lita A, et al. (2021) Cysteine is a limiting factor for glioma proliferation and survival. Molecular Oncology|
|Yuan Y, Wu J, Gilbert MR. (2021) BOIN: a novel Bayesian design platform to accelerate early phase brain tumor clinical trials. Neuro-Oncology Practice. 8: 627-638|
|Patil N, Somasundaram E, Waite KA, et al. (2021) Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Journal of Neuro-Oncology|
|Arakaki AKS, Szulzewsky F, Gilbert MR, et al. (2021) Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers. Neuro-Oncology. 23: S4-S15|
|Armstrong TS, Gilbert MR. (2021) Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors. Neuro-Oncology. 23: S30-S38|
|Wu Z, Abdullaev Z, Pratt D, et al. (2021) Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. Neuro-Oncology|
|Vezina A, Manglani M, Morris D, et al. (2021) Adenosine A2A receptor activation enhances blood-tumor barrier permeability in a rodent glioma model. Molecular Cancer Research : McR|